Our capability

Monash Vision Group has developed a platform of unique infrastructure, carefully curated to support the goal of growing a neurobionics research program with high translational potential. This is supported and supplemented by Monash University's unique infrastructure and platforms for imaging, testing and manufacturing. We can provide end-to-end preclinical manufacturing and testing capabilities, supported by advanced materials processing equipment, and instrumentation.

Our academic and clinical collaborators are world experts in a breadth of fields spanning materials science to neurosurgery. We leverage this expertise to develop transformational neurological prosthesis and brain-machine interface technologies. Our group's regulatory and commercialisation expertise ensures the translational potential of our research is exploited and enhanced, maximising its potential for clinical impact. Illustrating this, our bionic vision system Gennaris, was recently awarded Breakthrough Device designation by the United States FDA.

^{Caption: The Gennaris surgical delivery system, designed by engineers and neurosurgeons and tested in preclinical trials by MVG. Reproduction is forbidden without the express permission of Monash Vision Group.}

Monash Vision Group welcomes enquiries from industry partners, collaborators and prospective research students. We are actively seeking funding to grow our capabilities, including commercialising the outputs of our work.

Engagement opportunities include contract prototyping, process development or equipment rental, direct investment into new ventures or licensing of intellectual property. Monash University is a registered charity, and we also welcome enquiries from philanthropists or foundations looking to make a positive impact in neurological healthcare.

^{Caption: The implantable electronics of Gennaris, comprising a 43-channel neurostimulator (implemented on an Application Specific Integrated Circuit designed in-house) and associated wireless power and data circuitry on a custom printed circuit board.}

For investment, industry partnering, licensing or contract manufacturing enquiries, please contact Professor Arthur Lowery (arthur.lowery@monash.edu).

Clinical trials

Monash Vision Group are applying for funding to conduct the First-In-Human trial of Gennaris in a small number of study participants. This trial will be based at the Clayton campus of Monash University, with the procedure performed at The Alfred Hospital. We are not currently recruiting participants for this trial. However, we maintain an active register of expressions of interest in this trial, should funding be obtained.

If you are a citizen or permanent resident of Australia living in Victoria, have experienced profound vision loss and believe that the Gennaris bionic vision system could help, please register your interest by contacting monashvisiongroup@monash.edu. Please note this is an expression of interest only. It does not guarantee participation, nor does it place any obligation upon you to participate in our research, should funding be obtained for a clinical trial.